Loss of survival factors and activation of inflammatory cascades in brain sympathetic centers in type 1 diabetic mice

American Journal of Physiology - Endocrinology and Metabolism

Volumn 308, Issue 8, 2015, Pages E688-E698

  Hu, Ping ^a   Thinschmidt, Jeffrey S ^b   Caballero, Sergio ^b   Adamson, Samuel ^a   Cole, Louise ^a   Chan Ling, Tailoi ^a   Grant, Maria B ^c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF FLORIDA   (United States)

^c INDIANA UNIVERSITY   (United States)

Author keywords

Brain; Diabetes; Inflammation; Sympathetic nervous system

Indexed keywords

CD39 ANTIGEN; GELATINASE A; INDOLEAMINE 2,3 DIOXYGENASE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; AUTACOID; IDO1 PROTEIN, MOUSE; INSULIN-LIKE GROWTH FACTOR-1, MOUSE; MINOCYCLINE; NERVE PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADRENERGIC SYSTEM; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; CELL DENSITY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE DURATION; EXPERIMENTAL DIABETES MELLITUS; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MICROGLIA; MOUSE; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SURVIVAL FACTOR; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; COMPLICATION; DIABETES MELLITUS, TYPE 1; DIABETIC NEUROPATHIES; DISEASE COURSE; DOWN REGULATION; DRUG EFFECTS; ENCEPHALITIS; HYPOTHALAMUS; IMMUNOLOGY; MACROPHAGE; METABOLISM; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; UPREGULATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASTROCYTES; DIABETES MELLITUS, TYPE 1; DIABETIC NEUROPATHIES; DISEASE PROGRESSION; DOWN-REGULATION; ENCEPHALITIS; HYPOTHALAMUS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INFLAMMATION MEDIATORS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MACROPHAGES; MALE; MICE, INBRED C57BL; MICROGLIA; MINOCYCLINE; NERVE TISSUE PROTEINS; NEURONS; SYMPATHETIC NERVOUS SYSTEM; UP-REGULATION;

EID: 84929625899     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00504.2014     Document Type: Article

References (60)

1. Aksu I, Ates M, Baykara B, Kiray M, Sisman AR, Buyuk E, Baykara B, Cetinkaya C, Gumus H, Uysal N. Anxiety correlates to decreased blood and prefrontal cortex IGF-1 levels in streptozotocin induced diabetes. Neurosci Lett 531: 176–181, 2012.
2. Alder VA, Su EN, Yu DY, Cringle SJ, Yu PK. Diabetic retinopathy: early functional changes. Clin Exp Pharmacol Physiol 24: 785–788, 1997.
3. Andre C, O’Connor JC, Kelley KW, Lestage J, Dantzer R, Castanon N. Spatio-temporal differences in the profile of murine brain expression of proinflammatory cytokines and indoleamine 2,3-dioxygenase in response to peripheral lipopolysaccharide administration. J Neuroimmunol 200: 90–99, 2008.
4. Bondy CA, Cheng CM. Insulin-like growth factor-1 promotes neuronal glucose utilization during brain development and repair processes. Int Rev Neurobiol 51: 189–217, 2002.
5. Bulavina L, Szulzewsky F, Rocha A, Krabbe G, Robson SC, Matyash V, Kettenmann H. NTPDase1 activity attenuates microglial phagocytosis. Purinergic Signal 9: 199–205, 2013.
6. Butovsky O, Siddiqui S, Gabriely G, Lanser AJ, Dake B, Murugaiyan G, Doykan CE, Wu PM, Gali RR, Iyer LK, Lawson R, Berry J, Krichevsky AM, Cudkowicz ME, Weiner HL. Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J Clin Invest 122: 3063–3087, 2012.
7. Cai D, Liu T. Hypothalamic inflammation: a double-edged sword to nutritional diseases. Ann NY Acad Sci 1243: E1–E39, 2011.
8. Calegari VC, Torsoni AS, Vanzela EC, Araujo EP, Morari J, Zoppi CC, Sbragia L, Boschero AC, Velloso LA. Inflammation of the hypothalamus leads to defective pancreatic islet function. J Biol Chem 286: 12870–12880, 2011.
9. Campbell BM, Charych E, Lee AW, Moller T. Kynurenines in CNS disease: regulation by inflammatory cytokines. Front Neurosci 8: 12, 2014.
10. Cardona-Gómez GP, Mendez P, DonCarlos LL, Azcoitia I, Garcia- Segura LM. Interactions of estrogens and insulin-like growth factor-I in the brain: implications for neuroprotection. Brain Res Brain Res Rev 37: 320–334, 2001.
11. Carro E, Nuñez A, Busiguina S, Torres-Aleman I. Circulating insulinlike growth factor I mediates effects of exercise on the brain. J Neurosci 20: 2926–2933, 2000.
12. Carro E, Trejo JL, Núñez A, Torres-Aleman I. Brain repair and neuroprotection by serum insulin-like growth factor I. Mol Neurobiol 27: 153–162, 2003.
13. Chia JS, McRae JL, Cowan PJ, Dwyer KM. The CD39-adenosinergic axis in the pathogenesis of immune and nonimmune diabetes. J Biomed Biotechnol 2012: 320495, 2012.
14. Chia JS, McRae JL, Thomas HE, Fynch S, Elkerbout L, Hill P, Murray-Segal L, Robson SC, Chen JF, d’Apice AJ, Cowan PJ, Dwyer KM. The protective effects of CD39 overexpression in multiple low-dose streptozotocin-induced diabetes in mice. Diabetes 62: 2026–2035, 2013.
15. D’Ercole AJ, Ye P, Calikoglu AS, Gutierrez-Ospina G. The role of the insulin-like growth factors in the central nervous system. Mol Neurobiol 13: 227–255, 1996.
16. Daftary SS, Gore AC. IGF-1 in the brain as a regulator of reproductive neuroendocrine function. Exp Biol Med (Maywood) 230: 292–306, 2005.
17. Dheen ST, Tay SS, Wong WC. Ultrastructural changes in the hypothalamic paraventricular nucleus of the streptozotocin-induced diabetic rat. Acta Anat (Basel) 149: 291–299, 1994.
18. Ellsworth ML, Sprague RS. Regulation of blood flow distribution in skeletal muscle: role of erythrocyte-released ATP. J Physiol 590: 4985–4991, 2012.
19. Farber K, Markworth S, Pannasch U, Nolte C, Prinz V, Kronenberg G, Gertz K, Endres M, Bechmann I, Enjyoji K, Robson SC, Kettenmann H. The ectonucleotidase cd39/ENTPDase1 modulates purinergicmediated microglial migration. Glia 56: 331–341, 2008.
20. Fernstrom JD, Fernstrom MH, Kwok RP. In vivo somatostatin, vasopressin, and oxytocin synthesis in diabetic rat hypothalamus. Am J Physiol Endocrinol Metab 258: E661–E666, 1990.
21. Ferrante CJ, Pinhal-Enfield G, Elson G, Cronstein BN, Hasko G, Outram S, Leibovich SJ. The adenosine-dependent angiogenic switch of macrophages to an M2-like phenotype is independent of interleukin-4 receptor alpha (IL-4Ralpha) signaling. Inflammation 36: 921–931, 2013.
22. Fowlkes JL, Enghild JJ, Suzuki K, Nagase H. Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures. J Biol Chem 269: 25742–25746, 1994.
23. Fung CY, Marcus AJ, Broekman MJ, Mahaut-Smith MP. P2X(1) receptor inhibition and soluble CD39 administration as novel approaches to widen the cardiovascular therapeutic window. Trends Cardiovasc Med 19: 1–5, 2009.
24. García-Cáceres C, Yi CX, Tschöp MH. Hypothalamic astrocytes in obesity. Endocrinol Metab Clin North Am 42: 57–66, 2013.
25. Giebel SJ, Menicucci G, McGuire PG, Das A. Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier. Lab Invest 85: 597–607, 2005.
26. Herman JP, Flak J, Jankord R. Chronic stress plasticity in the hypothalamic paraventricular nucleus. Prog Brain Res 170: 353–364, 2008.
27. Hernandez-Guillamon M, Martinez-Saez E, Delgado P, Domingues-Montanari S, Boada C, Penalba A, Boada M, Pagola J, Maisterra O, Rodriguez-Luna D, Molina CA, Rovira A, Alvarez-Sabin J, Ortega-Aznar A, Montaner J. MMP-2/MMP-9 plasma level and brain expression in cerebral amyloid angiopathy-associated hemorrhagic stroke. Brain Pathol 22: 133–141, 2012.
28. Higashi Y, Sukhanov S, Anwar A, Shai SY, Delafontaine P. IGF-1, oxidative stress and atheroprotection. Trends Endocrinol Metab 21: 245–254, 2010.
29. Honda M, Eriksson KS, Zhang S, Tanaka S, Lin L, Salehi A, Hesla PE, Maehlen J, Gaus SE, Yanagisawa M, Sakurai T, Taheri S, Tsuchiya K, Honda Y, Mignot E. IGFBP3 colocalizes with and regulates hypocretin (orexin). PLoS One 4: e4254, 2009.
30. Hu P, Thinschmidt JS, Yan Y, Hazra S, Bhatwadekar A, Caballero S, Salazar T, Miyan JA, Li W, Derbenev A, Zsombok A, Tikhonenko M, Dominguez JM 2nd, McGorray SP, Saban DR, Boulton ME, Busik JV, Raizada MK, Chan-Ling T, Grant MB. CNS inflammation and bone marrow neuropathy in type 1 diabetes. Am J Pathol 183: 1608–1620, 2013.
31. Jarajapu YP, Cai J, Yan Y, Li Calzi S, Kielczewski JL, Hu P, Shaw LC, Firth SM, Chan-Ling T, Boulton ME, Baxter RC, Grant MB. Protection of blood retinal barrier and systemic vasculature by insulin-like growth factor binding protein-3. PLoS One 7: e39398, 2012.
32. Kaczmarek E, Koziak K, Sevigny J, Siegel JB, Anrather J, Beaudoin AR, Bach FH, Robson SC. Identification and characterization of CD39/ vascular ATP diphosphohydrolase. J Biol Chem 271: 33116–33122, 1996.
33. Kadoglou NP, Daskalopoulou SS, Perrea D, Liapis CD. Matrix metalloproteinases and diabetic vascular complications. Angiology 56: 173–189, 2005.
34. Khuth ST, Akaoka H, Pagenstecher A, Verlaeten O, Belin MF, Giraudon P, Bernard A. Morbillivirus infection of the mouse central nervous system induces region-specific upregulation of MMPs and TIMPs correlated to inflammatory cytokine expression. J Virol 75: 8268–8282, 2001.
35. Kielczewski JL, Hu P, Shaw LC, Li Calzi S, Mames RN, Gardiner TA, McFarland E, Chan-Ling T, Grant MB. Novel protective properties of IGFBP-3 result in enhanced pericyte ensheathment, reduced microglial activation, increased microglial apoptosis, and neuronal protection after ischemic retinal injury. Am J Pathol 178: 1517–1528, 2011.
36. Kielczewski JL, Jarajapu YP, McFarland EL, Cai J, Afzal A, Li Calzi S, Chang KH, Lydic T, Shaw LC, Busik J, Hughes J, Cardounel AJ, Wilson K, Lyons TJ, Boulton ME, Mames RN, Chan-Ling T, Grant MB. Insulin-like growth factor binding protein-3 mediates vascular repair by enhancing nitric oxide generation. Circ Res 105: 897–905, 2009.
37. Klein JP, Hains BC, Craner MJ, Black JA, Waxman SG. Apoptosis of vasopressinergic hypothalamic neurons in chronic diabetes mellitus. Neurobiol Dis 15: 221–228, 2004.
38. Kowluru RA, Kanwar M. Oxidative stress and the development of diabetic retinopathy: contributory role of matrix metalloproteinase-2. Free Radic Biol Med 46: 1677–1685, 2009.
39. Kowluru RA, Zhong Q, Santos JM. Matrix metalloproteinases in diabetic retinopathy: potential role of MMP-9. Expert Opin Investig Drugs 21: 797–805, 2012.
40. Kwidzinski E, Bechmann I. IDO expression in the brain: a double-edged sword. J Mol Med (Berl) 85: 1351–1359, 2007.
41. Levesque SA, Kukulski F, Enjyoji K, Robson SC, Sevigny J. NTPDase1 governs P2X7-dependent functions in murine macrophages. Eur J Immunol 40: 1473–1485, 2010.
42. Li ZG, Zhang W, Grunberger G, Sima AA. Hippocampal neuronal apoptosis in type 1 diabetes. Brain Res 946: 221–231, 2002.
43. Liou GI, Ahmad S, Naime M, Fatteh N, Ibrahim AS. Role of adenosine in diabetic retinopathy. J Ocul Biol Dis Infor 4: 19–24, 2011.
44. Lively S, Schlichter LC. The microglial activation state regulates migration and roles of matrix-dissolving enzymes for invasion. J Neuroinflammation 10: 75, 2013.
45. Luo Y, Kaur C, Ling EA. Neuronal and glial response in the rat hypothalamus-neurohypophysis complex with streptozotocin-induced diabetes. Brain Res 925: 42–54, 2002.
46. Marcus AJ, Broekman MJ, Drosopoulos JH, Islam N, Pinsky DJ, Sesti C, Levi R. Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseases. J Pharmacol Exp Ther 305: 9–16, 2003.
47. Markovic DS, Vinnakota K, van Rooijen N, Kiwit J, Synowitz M, Glass R, Kettenmann H. Minocycline reduces glioma expansion and invasion by attenuating microglial MT1-MMP expression. Brain Behav Immun 25: 624–628, 2011.
48. Mohammad G, Kowluru RA. Matrix metalloproteinase-2 in the development of diabetic retinopathy and mitochondrial dysfunction. Lab Invest 90: 1365–1372, 2010.
49. Nakano K, Migita M, Mochizuki H, Shimada T. Differentiation of transplanted bone marrow cells in the adult mouse brain. Transplantation 71: 1735–1740, 2001.
50. Obrosova IG, Drel VR, Pacher P, Ilnytska O, Wang ZQ, Stevens MJ, Yorek MA. Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited. Diabetes 54: 3435–3441, 2005.
51. Obrosova IG, Li F, Abatan OI, Forsell MA, Komjati K, Pacher P, Szabo C, Stevens MJ. Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy. Diabetes 53: 711–720, 2004.
52. Salmi M, Jalkanen S. Ectoenzymes controlling leukocyte traffic. Eur J Immunol 42: 284–292, 2012.
53. Schwarcz R, Bruno JP, Muchowski PJ, Wu HQ. Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci 13: 465–477, 2012.
54. Signorelli SS, Malaponte G, Libra M, Di Pino L, Celotta G, Bevelacqua V, Petrina M, Nicotra GS, Indelicato M, Navolanic PM, Pennisi G, Mazzarino MC. Plasma levels and zymographic activities of matrix metalloproteinases 2 and 9 in type II diabetics with peripheral arterial disease. Vasc Med 10: 1–6, 2005.
55. Sugiyama T. Role of P2X7 receptors in the development of diabetic retinopathy. World J Diabetes 5: 141–145, 2014.
56. Suk K. Minocycline suppresses hypoxic activation of rodent microglia in culture. Neurosci Lett 366: 167–171, 2004.
57. Taylor MW, Feng GS. Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J 5: 2516–2522, 1991.
58. Trejo JL, Piriz J, Llorens-Martin MV, Fernandez AM, Bolós M, LeRoith D, Nuñez A, Torres-Aleman I. Central actions of liver-derived insulin-like growth factor I underlying its pro-cognitive effects. Mol Psychiatry 12: 1118–1128, 2007.
59. Xu M, Zhang HL. Death and survival of neuronal and astrocytic cells in ischemic brain injury: a role of autophagy. Acta Pharmacol Sin 32: 1089–1099, 2011.
60. Yegutkin GG. Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade. Biochim Biophys Acta 1783: 673–694, 2008.